Teresa Bitetti

Teresa Bitetti is President of the Global Oncology Business Unit at Takeda. Given her strong expertise and experience in product commercialization and launches, Teresa understands the importance of close alignment with R&D to accelerate the science and to bring meaningful medicines to patients quickly and efficiently. Prior to Takeda, Teresa was Senior Vice President, Head of Worldwide Oncology Commercialization at Bristol Myers Squibb (BMS) that included the blockbuster drug, Opdivo, and the entire US portfolio. Teresa holds an MBA in Finance from the Darden School of Business at the University of Virginia and a BA from Wellesley College.